3+ day, 2+ hour ago  (229+ words) DUPILUMAB has demonstrated significant and clinically meaningful improvements in disease activity and severity among patients with prurigo nodularis (PN), according to a new post hoc analysis of pooled data from the Phase III PRIME and PRIME2 trials. At 24 weeks, dupilumab-treated patients…...

2+ week, 6+ day ago  (684+ words) Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo BP is a chronic, relapsing skin disease with underlying type 2 inflammation characterized by intense…...

6+ day, 16+ min ago  (811+ words) Review your profile in our search tool for the public, which helps patients find board-certified dermatologists. Make sure your contact info is up to date in our directory. This listing is for AAD members only. Explore the Academy's new and…...

2+ week, 3+ day ago  (192+ words) Poster #76929 highlights a qualitative patient and caregiver interview study evaluating the burden of living with porokeratosis, a serious, rare genetic skin disease characterized by numerous pre-cancerous, pruritic lesions and substantial functional and psychosocial burden The details of the poster presentations…...

1+ week, 6+ day ago  (238+ words) Patients with seborrheic dermatitis have significantly increased odds of developing scarring alopecia, according to study results presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting held in Denver, Colorado from March 37 to 31. Among the patients, 51% were women, 57% were White,…...

1+ week, 6+ day ago  (719+ words) One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasis Results further support the differentiated profile of ICOTYDE, the first and only…...

2+ week, 2+ day ago  (515+ words) Broad and meaningful clinical benefits emerged early. Notably, quality-of-life and itch improvements appeared before PASI 90 skin clearance responses and continued to deepen through Week 24 across. .. Alumis" Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis…...

1+ week, 3+ day ago  (371+ words) Monday, April 13 2026, 08: 58 AM The first step in controlling acne is understanding that it is a medical condition influenced by multiple factors, including excess oil production, clogged pores, bacteria, and inflammation. Hormonal fluctuations, stress, diet, and improper skincare can further aggravate…...

1+ day, 6+ hour ago  (547+ words) Pragativadi | Odisha's Trusted News Source in English Pragativadi is a leading digital news organization committed to delivering timely, accurate, and culturally resonant coverage from Odisha and beyond. With a strong editorial focus on public interest journalism, Pragativadi bridges the gap…...

1+ day, 11+ hour ago  (179+ words) Alopecia areata totalis'is a variant of alopecia areata, a common autoimmune disorder resulting in non-scarring hair loss. Although its pathogenesis remains unclear, both genetic predisposition and environmental triggers have been implicated, of which chronic inflammatory and infectious conditions are considered…...